Singapore's public hospitals announced last Monday they will no longer subsidize COVID-19 treatment for unvaccinated patients eligible for vaccination. This move addresses the heavy burden these cases place on the healthcare system, sparking debate on fairness versus necessity.
Over the past 15 weeks, new COVID-19 cases and ICU admissions have stabilized in Singapore, though ICU numbers remain high. Authorities attribute this to widespread vaccinations and boosters, yet unvaccinated individuals still represent a disproportionate share of severe cases straining resources.
In response, hospitals are implementing a firm policy. The Monday statement confirms that subsidized COVID-19 care will end for those who voluntarily refused vaccination. Officials reason that such patients should cover their own treatment costs.
Singapore's privatized healthcare system receives government subsidies based on conditions. During the pandemic, all COVID-19 care was fully covered. Now, subsidies will apply only to vaccinated patients.
Exemptions remain for children under 12 and those medically unable to vaccinate, ensuring their care stays free.
Reactions are mixed, as IFLScience reports. Some decry it as inequitable; others praise it for protecting overwhelmed hospitals.
Similar restrictions have emerged elsewhere. In the US, some hospitals prioritize vaccinated patients for organ transplants, deprioritizing the unvaccinated.
This stems from post-transplant immunosuppressive drugs, which raise COVID-19 infection and mortality risks by 20-30%. Doctors aim to safeguard precious organs from higher-risk recipients.
